title: FDG PET/CT in children and adolescents with lymphoma.
abstract: The aim of this review is to give an overview of FDG PET/CT applications in children and adolescents with lymphoma. Today, FDG PET is used for tailoring treatment intensity in children with Hodgkin lymphoma within the framework of international treatment optimisation protocols. In contrast, the role of this method in children with Non-Hodgkin lymphoma is not well defined. This paper overviews clinical appearance and metabolic behaviour of the most frequent lymphoma subtypes in childhood. The main focus of the review is to summarise knowledge about the role of FDG PET/CT for initial staging and early response assessment.
authors.affiliation: Department of Nuclear Medicine, University Hospital Leipzig, Liebigstrasse 18, 04103, Leipzig, Germany. Regine.Kluge@medizin.uni-leipzig.de
authors.forename: Regine
authors.initials: R
authors.lastname: Kluge
authors.forename: Lars
authors.initials: L
authors.lastname: Kurch
authors.forename: Françoise
authors.initials: F
authors.lastname: Montravers
authors.forename: Christine
authors.initials: C
authors.lastname: Mauz-Körholz
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D007223:Infant; D007231:Infant, Newborn; D008223:Lymphoma / Q000175:diagnosis*; D008297:Male; D064847:Multimodal Imaging / Q000379:methods*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18